2008
DOI: 10.1196/annals.1433.035
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of Hyperglycemia‐Induced Angiogenesis Deficit of Human Endothelial Cells by Overexpression of Glyoxalase 1In Vitro

Abstract: Dicarbonyl glycation of RGD and GFOGER sites in type IV collagen has been associated with decreased angiogenesis. In this study, we investigated whether overexpression of glyoxalase 1 to decrease dicarbonyl glycation would prevent the angiogenesis deficit induced by hyperglycemia in vitro. Transfection of human microvascular endothelial cells resulted in a four-fold increase in glyoxalase 1 activity compared with controls. Incubation of human microvascular endothelial cells in model hyperglycemia produced a 32… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
40
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 44 publications
(41 citation statements)
references
References 20 publications
1
40
0
Order By: Relevance
“…The increase in MG found in our study was of similar level achieved with the GLO1 inhibitor BBGD that increased EC anoikis15 and was prevented by overexpression of GLO116. Similar proportionate increases in the MG concentration of culture medium are expected as MG permeates cell membranes with a half-life of <15 min23.…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…The increase in MG found in our study was of similar level achieved with the GLO1 inhibitor BBGD that increased EC anoikis15 and was prevented by overexpression of GLO116. Similar proportionate increases in the MG concentration of culture medium are expected as MG permeates cell membranes with a half-life of <15 min23.…”
Section: Discussionsupporting
confidence: 84%
“…Increased MG concentration in cells and culture medium leads to increased formation of MG-H1 in integrin binding sites of collagen type-IV, resulting in endothelial cell detachment and anoikis15. Increased glycation of cellular proteins is likely linked to increased formation of ROS and inflammatory signalling1416. Conversely, inhibition of GLO1 with a specific GLO1 inhibitor, S-p-bromobenzylglutathione cyclopentyl diester (BBGSHCp 2 ) led to accumulation of MG in low glucose concentration and dysfunction similar to that found in the hyperglycaemia model15.…”
mentioning
confidence: 99%
“…Experimental evidence is currently best established for vascular complications of diabetes. In cell culture systems incubated in high glucose concentrations to model diabetes associated hyperglycemia, overexpression of Glo1 prevented increased formation of ROS, inflammatory mediators S100A8, S100A12 and high mobility box-1 protein, and increased expression of the receptor for advanced glycation endproducts (RAGE) [47], and corrected decreased angiogenesis of endothelial cells [48] and dysfunction of endothelial progenitor cells [49]. Employing Glo1 transgenic rats, overexpression of Glo1 in vivo decreased the AGE and oxidative damage marker contents of tissues and prevented impairment of endothelium-dependent vasorelaxation of the streptozotocin-induced diabetic rats [37;50].…”
Section: Discussionmentioning
confidence: 99%
“…A fraction of GSH is present as S-nitroso-GSH, a transnitrosylating agent generated from nitric oxide or its metabolites (168). 4) GSH functions in metabolism as a coenzyme for formaldehyde dehydrogenase, glyoxylase, and other metabolic reactions (4,168). In these reactions, GSH is cyclically removed by one reaction and regenerated in a second reaction.…”
Section: Gsh and Trxs As Common Control Nodes For Protein Thiol Redoxmentioning
confidence: 99%